Thiopeps – Thiostrepton derivatives as new antibiotics and specifically designed molecular sensors
An increasing problem in modern medicine is the growing
resistance of microorganisms against antibiotics and the resulting race for new antibiotic candidates. Inventors from the University of Dortmund have found a way to get to both, new antibiotics and a method to identify them. Common thiopeptides like thiostrepton are potent inhibitors of the bacterial protein-biosynthesis. Most prokaryotic ribosomes are known to be thiopeptide sensitive. Mitochondrial ribosomes from protozoa (e.g. Plasmodium, Toxoplasma) and from multicellular organisms (cancer cell lines) are also affected, but not the cytoplasmic ribosomes in eukaryotes. No thiopeptide antibiotic is in human pharmaceutical application so far. The inventions provide novel compounds binding not only to prokaryotic but also to mitochondrial ribosomes. The disclosed compounds are thiostrepton derivatives and inhibit protein biosynthesis. They are stable and show both high affinity and selectivity.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 0
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Lighting up the future
New multidisciplinary research from the University of St Andrews could lead to more efficient televisions, computer screens and lighting. Researchers at the Organic Semiconductor Centre in the School of Physics and…
Researchers crack sugarcane’s complex genetic code
Sweet success: Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance in plants….
Evolution of the most powerful ocean current on Earth
The Antarctic Circumpolar Current plays an important part in global overturning circulation, the exchange of heat and CO2 between the ocean and atmosphere, and the stability of Antarctica’s ice sheets….